397 related articles for article (PubMed ID: 16520178)
1. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T
J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178
[TBL] [Abstract][Full Text] [Related]
2. Thrombogenicity of a new injectable biocompatible elastomer for aneurysm exclusion, compared to expanded polytetrafluoroethylene in a human ex vivo model.
van der Steenhoven TJ; Bosman WM; Tersteeg C; Jacobs MJ; Moll FL; de Groot PG; Heyligers JM
Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):675-80. PubMed ID: 22436262
[TBL] [Abstract][Full Text] [Related]
3. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
5. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
6. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
[TBL] [Abstract][Full Text] [Related]
7. Overcoming failure of venous vascular prostheses.
Plate G; Hollier LH; Gloviczki P; Dewanjee MK; Kaye MP
Surgery; 1984 Sep; 96(3):503-10. PubMed ID: 6474355
[TBL] [Abstract][Full Text] [Related]
8. Platelet deposition on ePTFE grafts coated with fibrin glue with or without FGF-1 and heparin.
Zarge JI; Gosselin C; Huang P; Vorp DA; Severyn DA; Greisler HP
J Surg Res; 1997 Jan; 67(1):4-8. PubMed ID: 9070173
[TBL] [Abstract][Full Text] [Related]
9. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
Gessaroli M; Bombardi C; Giunti M; Bacci ML
J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of ibuprofen treatment on thrombogenicity of expanded polytetrafluoroethylene vascular grafts.
Gloviczki P; Hollier LH; Dewanjee MK; Trastek VF; Kopesky KR; Kaye MP
Surgery; 1984 Feb; 95(2):160-8. PubMed ID: 6695334
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
[TBL] [Abstract][Full Text] [Related]
12. Improvement of patency rate in heparin-coated small synthetic vascular grafts.
Walpoth BH; Rogulenko R; Tikhvinskaia E; Gogolewski S; Schaffner T; Hess OM; Althaus U
Circulation; 1998 Nov; 98(19 Suppl):II319-23; discussion II324. PubMed ID: 9852921
[TBL] [Abstract][Full Text] [Related]
13. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results.
Daenens K; Schepers S; Fourneau I; Houthoofd S; Nevelsteen A
J Vasc Surg; 2009 May; 49(5):1210-6. PubMed ID: 19394550
[TBL] [Abstract][Full Text] [Related]
14. Thrombogenesis of different cell types seeded on vascular grafts and studied under blood-flow conditions.
Hedeman Joosten PP; Verhagen HJ; Heijnen-Snyder GJ; van Vroonhoven TJ; Sixma JJ; de Groot PG; Eikelboom BC
J Vasc Surg; 1998 Dec; 28(6):1094-103. PubMed ID: 9845661
[TBL] [Abstract][Full Text] [Related]
15. Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding.
Esquivel CO; Björck CG; Bergentz SE; Bergqvist D; Larsson R; Carson SN; Dougan P; Nilsson B
Surgery; 1984 Jan; 95(1):102-7. PubMed ID: 6691173
[TBL] [Abstract][Full Text] [Related]
16. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
Laredo J; Xue L; Husak VA; Ellinger J; Greisler HP
Am J Surg; 2003 Nov; 186(5):556-60. PubMed ID: 14599625
[TBL] [Abstract][Full Text] [Related]
17. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
[TBL] [Abstract][Full Text] [Related]
18. Heparinization of polytetrafluoroethylene (ePTFE) grafts. The effect on pseudointimal hyperplasia.
Bergqvist D; Jensen N; Persson NH
Int Angiol; 1988; 7(1):65-70. PubMed ID: 3385270
[TBL] [Abstract][Full Text] [Related]
19. Local hemodynamic disturbance accelerates early thrombosis of small-caliber expanded polytetrafluoroethylene grafts.
Lu S; Sun X; Zhang P; Yang L; Gong F; Wang C
Perfusion; 2013 Sep; 28(5):440-8. PubMed ID: 23703290
[TBL] [Abstract][Full Text] [Related]
20. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
